|
Mechanismβ2-adrenergic receptor agonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1999 |
|
Mechanismβ2-adrenergic receptor agonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Approval |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanismβ2-adrenergic receptor agonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Suzhou Kaifa Biotechnology Co. Ltd.
0 Patents (Medical) associated with Suzhou Kaifa Biotechnology Co. Ltd.
100 Deals associated with Suzhou Kaifa Biotechnology Co. Ltd.
100 Translational Medicine associated with Suzhou Kaifa Biotechnology Co. Ltd.